Literature DB >> 10411211

Medicinal plants and Alzheimer's disease: from ethnobotany to phytotherapy.

E K Perry1, A T Pickering, W W Wang, P J Houghton, N S Perry.   

Abstract

The use of complementary medicines, such as plant extracts, in dementia therapy varies according to the different cultural traditions. In orthodox Western medicine, contrasting with that in China and the Far East for example, pharmacological properties of traditional cognitive- or memory-enhancing plants have not been widely investigated in the context of current models of Alzheimer's disease. An exception is Gingko biloba in which the gingkolides have antioxidant, neuroprotective and cholinergic activities relevant to Alzheimer's disease mechanisms. The therapeutic efficacy of Ginkgo extracts in Alzheimer's disease in placebo controlled clinical trials is reportedly similar to currently prescribed drugs such as tacrine or donepezil and, importantly, undesirable side effects of Gingko are minimal. Old European reference books, such as those on medicinal herbs, document a variety of other plants such as Salvia officinalis (sage) and Melissa officinalis (balm) with memory-improving properties, and cholinergic activities have recently been identified in extracts of these plants. Precedents for modern discovery of clinically relevant pharmacological activity in plants with long-established medicinal use include, for example, the interaction of alkaloid opioids in Papaver somniferum (opium poppy) with endogenous opiate receptors in the brain. With recent major advances in understanding the neurobiology of Alzheimer's disease, and as yet limited efficacy of so-called rationally designed therapies, it may be timely to re-explore historical archives for new directions in drug development. This article considers not only the value of an integrative traditional and modern scientific approach to developing new treatments for dementia, but also in the understanding of disease mechanisms. Long before the current biologically-based hypothesis of cholinergic derangement in Alzheimer' s disease emerged, plants now known to contain cholinergic antagonists were recorded for their amnesia- and dementia-inducing properties.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10411211     DOI: 10.1211/0022357991772808

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  26 in total

1.  An extract of Salvia (sage) with anticholinesterase properties improves memory and attention in healthy older volunteers.

Authors:  Andrew B Scholey; Nicola T J Tildesley; Clive G Ballard; Keith A Wesnes; Andrea Tasker; Elaine K Perry; David O Kennedy
Journal:  Psychopharmacology (Berl)       Date:  2008-03-19       Impact factor: 4.530

Review 2.  Inflammation and Alzheimer's disease.

Authors:  H Akiyama; S Barger; S Barnum; B Bradt; J Bauer; G M Cole; N R Cooper; P Eikelenboom; M Emmerling; B L Fiebich; C E Finch; S Frautschy; W S Griffin; H Hampel; M Hull; G Landreth; L Lue; R Mrak; I R Mackenzie; P L McGeer; M K O'Banion; J Pachter; G Pasinetti; C Plata-Salaman; J Rogers; R Rydel; Y Shen; W Streit; R Strohmeyer; I Tooyoma; F L Van Muiswinkel; R Veerhuis; D Walker; S Webster; B Wegrzyniak; G Wenk; T Wyss-Coray
Journal:  Neurobiol Aging       Date:  2000 May-Jun       Impact factor: 4.673

3.  Antioxidant activity and total phenolic content of Moringa oleifera leaves in two stages of maturity.

Authors:  S Sreelatha; P R Padma
Journal:  Plant Foods Hum Nutr       Date:  2009-12       Impact factor: 3.921

4.  Antioxidant effects of different extracts from Melissa officinalis, Matricaria recutita and Cymbopogon citratus.

Authors:  Romaiana Picada Pereira; Roselei Fachinetto; Alessandro de Souza Prestes; Robson Luiz Puntel; Gloria Narjara Santos da Silva; Berta Maria Heinzmann; Ticiane Krapf Boschetti; Margareth Linde Athayde; Marilise Escobar Bürger; Ademir Farias Morel; Vera Maria Morsch; João Batista Teixeira Rocha
Journal:  Neurochem Res       Date:  2008-10-14       Impact factor: 3.996

5.  Effects of Various Flavonoids on the α-Synuclein Fibrillation Process.

Authors:  Xiaoyun Meng; Larissa A Munishkina; Anthony L Fink; Vladimir N Uversky
Journal:  Parkinsons Dis       Date:  2010-01-28

6.  Neuroprotective effect of baicalein on hydrogen peroxide-mediated oxidative stress and mitochondrial dysfunction in PC12 cells.

Authors:  Shehua Zhang; Junli Ye; Guoxiong Dong
Journal:  J Mol Neurosci       Date:  2010-03       Impact factor: 3.444

7.  Melissa officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomised, placebo controlled trial.

Authors:  S Akhondzadeh; M Noroozian; M Mohammadi; S Ohadinia; A H Jamshidi; M Khani
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-07       Impact factor: 10.154

8.  Effect of plant extracts on Alzheimer's disease: An insight into therapeutic avenues.

Authors:  M Obulesu; Dowlathabad Muralidhara Rao
Journal:  J Neurosci Rural Pract       Date:  2011-01

9.  Management of anemia of inflammation in the elderly.

Authors:  Antonio Macciò; Clelia Madeddu
Journal:  Anemia       Date:  2012-10-03

10.  Ayurvedic medicinal plants for Alzheimer's disease: a review.

Authors:  Rammohan V Rao; Olivier Descamps; Varghese John; Dale E Bredesen
Journal:  Alzheimers Res Ther       Date:  2012-06-29       Impact factor: 6.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.